NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 13 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 109,251,000 | $102,018,584 | 3.22% |
| Opti Capital Management, LP | 19,500,000 | $18,574 | 1.34% |
| Context Capital Management, LLC | 10,702 | $10,207 | 0.82% |
| PFM Health Sciences, LP | 17,500,000 | $16,341,500 | 0.77% |
| LINDEN ADVISORS LP | 21,366,000 | $19,993,448 | 0.20% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,595,000 | $1,543,041 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,667,000 | $6,225,645 | 0.03% |
| Rock Springs Capital Management LP | 500,000 | $472,128 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 0 | $933 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |